What is Catheter Precision?
Catheter Precision operates at the intersection of medical technology and patient-centric cardiac care. The company specializes in the development of sophisticated electrophysiology tools designed to address the complexities of cardiac arrhythmias. Their product portfolio, which includes the eIFU, Vivo, and LockeT systems, serves as a critical resource for healthcare providers and medical professionals. By focusing on high-precision instrumentation, Catheter Precision aims to standardize outcomes and improve the quality of life for patients suffering from irregular heart rhythms, establishing itself as a pivotal player in the cardiovascular health sector.
How much funding has Catheter Precision raised?
Catheter Precision has raised a total of $1.6M across 2 funding rounds:
Debt
$150K
Stock/Share Issuance
$1.5M
Debt (2020): $150K with participation from PPP
Stock/Share Issuance (2025): $1.5M, investors not publicly disclosed
Key Investors in Catheter Precision
PPP
Public-Private Partnership
Undisclosed Investor
A private capital partner participating in the latest strategic financing round to support long-term medical innovation.
Undisclosed Investor
An institutional backer focused on high-growth opportunities within the healthcare and medical technology sectors.
What's next for Catheter Precision?
With the recent infusion of capital, Catheter Precision is poised to scale its operational capabilities and expand its market footprint. The company is expected to prioritize the commercialization of its core technologies while potentially investing in research and development to broaden its diagnostic and therapeutic offerings. As the firm transitions into this next phase of growth, the focus will likely remain on clinical validation and the integration of its innovative systems into standard hospital workflows, ensuring that medical professionals have the necessary tools to deliver superior patient care in an increasingly complex cardiac environment.
See full Catheter Precision company page
